응고 분석기 시장 보고서(2026년)
Coagulation Analyzer Global Market Report 2026
상품코드 : 1942578
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,759,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,770,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,780,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

응고 분석기 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 32억 6,000만 달러에서 2026년에는 35억 3,000만 달러로, CAGR 8.2%로 확대할 전망입니다. 지난 수년간의 성장에는 심혈관 질환 유병률 증가, 항응고제 모니터링 확대, 병원 진단 인프라 확충, 표준화된 응고 검사 프로토콜 채택, 수술 건수 증가 등이 주요 요인으로 꼽힙니다.

응고 분석기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 49억 5,000만 달러에 달하며, CAGR은 8.8%에 달할 전망입니다. 예측 기간 중의 성장에는 신속한 응고 진단에 대한 수요 증가, 분산형 검사 환경의 확대, 첨단 혈액 분석 장비에 대한 투자 증가, 환자 안전 모니터링에 대한 관심 증가, 스마트 진단 플랫폼의 통합 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 완전 자동화 응고 시스템 도입 증가, 고감도 응고 검사에 대한 수요 증가, AI 지원을 통한 결과 해석의 통합 발전, Point-of-Care 응고 검사 확대, 워크플로우 자동화에 대한 집중도 강화 등을 들 수 있습니다.

심장 질환의 발생률 증가는 향후 수년간 응고 분석기 시장의 성장을 촉진할 것으로 예측됩니다. 심장질환에는 심장과 혈관 모두에 영향을 미치는 다양한 질환이 포함됩니다. 응고분석기는 혈액응고 매개변수 평가, 항응고요법 가이드라인 제공, 합병증 예방을 통해 심장질환 관리에 활용되어 효과적인 치료와 관리에 기여합니다. 예를 들어 미국 질병예방통제센터(CDC)의 2024년 10월 발표에 따르면 2023년 심혈관 질환으로 인한 사망자 수는 91만 9,032명으로 전체 사망자 3명 중 1명이 심혈관 질환으로 사망한 것으로 나타났습니다. 관상동맥성 심장질환은 여전히 가장 흔한 심장질환으로, 특히 심혈관 질환으로 인한 사망자 6명 중 1명은 65세 미만의 성인으로 나타났습니다. 따라서 심장 질환 발생률 증가는 응고 분석기 시장의 성장을 가속하고 있습니다.

응고 분석기 시장의 주요 기업은 최소한의 인위적 개입으로 높은 검사량을 관리하기 위해 전자동 응고 분석기와 같은 기술적으로 진보된 제품을 개발하고 있습니다. 전자동 응고 분석기는 혈액 응고 과정을 자동으로 검사하는 실험실 장비로, 수동 입력 없이 응고 장애를 정확하고 효율적으로 진단할 수 있습니다. 예를 들어 2024년 3월 중국 체외진단용 시약 및 기기 공급업체인 자이바이오(Zybio Inc.)는 EXT 9800 전자동 응고 분석기를 출시했습니다. EXT 9800은 응고 과정의 시각화 및 다차원 분석을 가능하게 하는 미세 자성 입자 검출 기술을 최초로 채택하여 정확도와 분석의 깊이를 향상시켰습니다는 점이 특징입니다. 분산형 구조, 모듈식 확장성, 높은 처리량으로 자동 검출을 재정의하고 실험실에 가볍고 종합적인 솔루션을 제공합니다. 또한 전체 검사 프로세스를 완전히 업그레이드하여 응고 검사의 혁신에 대한 새로운 표준을 확립했습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

A coagulation analyzer is a medical device designed to swiftly and efficiently measure blood platelet levels. Its primary function involves assessing the blood's clotting ability, enabling the identification and evaluation of bleeding disorders such as hemophilia. Additionally, it aids in monitoring patients who are prescribed anticoagulant medications such as aspirin, heparin, or warfarin.

The principal product categories of coagulation analyzers comprise semi-automated coagulation analyzers, automated coagulation analyzers, manual analyzers, and other specialized variants. Semi-automated coagulation analyzers serve as essential medical diagnostic tools for assessing various components present in human blood. These analyzers facilitate multiple test types, including prothrombin time testing, fibrinogen testing, activated partial thromboplastin time testing, d-dimer testing, platelet function testing, anti-factor Xa testing, among others. These tests utilize diverse technologies such as optical, mechanical, electrochemical, and other advanced methodologies. Coagulation analyzers cater to a range of end-users, including hospitals, clinics, diagnostic centers, and other medical facilities where the accurate assessment of blood coagulation is crucial for diagnosis and treatment purposes.

Tariffs are influencing the coagulation analyzer market by increasing costs of imported optical sensors, reagents, microfluidic components, and electronic control systems used in automated analyzers. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported devices, while Asia-Pacific faces higher costs for analyzer exports. These tariffs are raising procurement expenses and slowing replacement cycles. However, they are also encouraging local analyzer assembly, domestic reagent production, and long-term supply chain localization.

The coagulation analyzer market research report is one of a series of new reports from The Business Research Company that provides coagulation analyzer market statistics, including coagulation analyzer industry global market size, regional shares, competitors with a coagulation analyzer market share, detailed coagulation analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation analyzer industry. This coagulation analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coagulation analyzer market size has grown strongly in recent years. It will grow from $3.26 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular disorders, growth in anticoagulant therapy monitoring, expansion of hospital diagnostic infrastructure, adoption of standardized coagulation testing protocols, rising surgical procedure volumes.

The coagulation analyzer market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing demand for rapid coagulation diagnostics, expansion of decentralized testing environments, rising investments in advanced hematology analyzers, growing focus on patient safety monitoring, integration of smart diagnostics platforms. Major trends in the forecast period include increasing adoption of fully automated coagulation systems, rising demand for high-sensitivity clotting assays, growing integration of ai-assisted result interpretation, expansion of point-of-care coagulation testing, enhanced focus on workflow automation.

The rising incidence of cardiac diseases is expected to drive the growth of the coagulation analyzer market in the coming years. Cardiac diseases include a variety of conditions that affect both the heart and blood vessels. Coagulation analyzers are utilized in the management of cardiac diseases by assessing blood clotting parameters, guiding anticoagulant therapy, and preventing complications, thereby contributing to effective treatment and care. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most prevalent form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 year. Therefore, the rising incidence of cardiac diseases is driving the growth of the coagulation analyzer market.

Major companies in the coagulation analyzer market are developing technologically advanced products, such as fully automated coagulation analyzers, to manage high test volumes with minimal human intervention. A fully automated coagulation analyzer is a laboratory device that performs automated testing of blood clotting processes, enabling accurate and efficient diagnosis of coagulation disorders without the need for manual input. For example, in March 2024, Zybio Inc., a China-based provider of in vitro diagnostic reagents and equipment, launched the EXT 9800 fully automated coagulation analyzer. The EXT 9800 is notable for being the first to employ micro magnetic particle detection, allowing for visualized, multi-dimensional analysis of the coagulation process, which enhances accuracy and depth. It redefines automated detection with a distributed structure, modular expandability, and high-throughput capabilities, offering a lightweight, comprehensive solution for laboratories. Additionally, the analyzer features a complete upgrade across the entire testing process, establishing a new standard for innovation in coagulation testing.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a medical device company based in China, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition will enable Mindray to accelerate the development of its overseas supply chain platform, access a skilled international team, and enhance its in-vitro diagnostics portfolio. Mindray is committed to providing resources and support to DiaSys while leveraging its extensive experience in global integration to promote effective synergistic growth for both companies. DiaSys Diagnostic Systems GmbH is a manufacturer of coagulation analyzers based in Germany.

Major companies operating in the coagulation analyzer market are Siemens AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Werfen S.A., Nihon Kohden Corporation, Diagnostica Stago SAS, ARKRAY Inc., Beckman Coulter Inc., Helena Laboratories Corporation, Maccura Biotechnology Co. Ltd., Beijing Succeeder Technology Inc., Trivitron Healthcare Pvt. Ltd., A&T Corporation, ACON Laboratories Inc., Genrui Biotech Inc., Teco Medical Instruments, Eurolyser Diagnostica GmbH, Meril Life Science Pvt. Ltd., Bioevopeak Co. Ltd.

North America was the largest region in the coagulation analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coagulation analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coagulation analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The coagulation analyzer market consists of sales of hematology coagulation analyzers, standalone coagulation analyzers, and portable analyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coagulation Analyzer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses coagulation analyzer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coagulation analyzer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation analyzer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Coagulation Analyzer Market Characteristics

3. Coagulation Analyzer Market Supply Chain Analysis

4. Global Coagulation Analyzer Market Trends And Strategies

5. Coagulation Analyzer Market Analysis Of End Use Industries

6. Coagulation Analyzer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Coagulation Analyzer Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Coagulation Analyzer Total Addressable Market (TAM) Analysis for the Market

9. Coagulation Analyzer Market Segmentation

10. Coagulation Analyzer Market Regional And Country Analysis

11. Asia-Pacific Coagulation Analyzer Market

12. China Coagulation Analyzer Market

13. India Coagulation Analyzer Market

14. Japan Coagulation Analyzer Market

15. Australia Coagulation Analyzer Market

16. Indonesia Coagulation Analyzer Market

17. South Korea Coagulation Analyzer Market

18. Taiwan Coagulation Analyzer Market

19. South East Asia Coagulation Analyzer Market

20. Western Europe Coagulation Analyzer Market

21. UK Coagulation Analyzer Market

22. Germany Coagulation Analyzer Market

23. France Coagulation Analyzer Market

24. Italy Coagulation Analyzer Market

25. Spain Coagulation Analyzer Market

26. Eastern Europe Coagulation Analyzer Market

27. Russia Coagulation Analyzer Market

28. North America Coagulation Analyzer Market

29. USA Coagulation Analyzer Market

30. Canada Coagulation Analyzer Market

31. South America Coagulation Analyzer Market

32. Brazil Coagulation Analyzer Market

33. Middle East Coagulation Analyzer Market

34. Africa Coagulation Analyzer Market

35. Coagulation Analyzer Market Regulatory and Investment Landscape

36. Coagulation Analyzer Market Competitive Landscape And Company Profiles

37. Coagulation Analyzer Market Other Major And Innovative Companies

38. Global Coagulation Analyzer Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Coagulation Analyzer Market

40. Coagulation Analyzer Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기